{"url":"https://lda.senate.gov/api/v1/filings/07b3ca4b-5be9-44a5-9bb4-e1801e611313/","filing_uuid":"07b3ca4b-5be9-44a5-9bb4-e1801e611313","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2022,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/07b3ca4b-5be9-44a5-9bb4-e1801e611313/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Tongour","dt_posted":"2022-10-13T09:27:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 M St NW","registrant_address_2":"Suite 500, South Tower","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":51478,"url":"https://lda.senate.gov/api/v1/registrants/51478/","house_registrant_id":34927,"name":"TCH GROUP, LLC","description":"Government relations consulting firm","address_1":"4937 Tilden St NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20016","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL A. TONGOUR","contact_telephone":"+1 202-321-3579","dt_updated":"2026-07-18T07:44:30.034211-04:00"},"client":{"id":213844,"url":"https://lda.senate.gov/api/v1/clients/213844/","client_id":1004633,"name":"TRUEPILL","general_description":"Healthcare","client_government_entity":null,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Accessibility and affordability of prescription drugs, including issues pertaining to vulnerable patients, ie, the 340B program and Medicaid","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18004,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TONGOUR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}